Cargando…

Cost-Effectiveness of Liver Cancer Screening in Adults at High Risk for Liver Cancer in the Republic of Korea

PURPOSE: This study was conducted in order to determine the most cost-effective strategy, in terms of interval and age range, forliver cancer screening in the high-risk population of Korea. MATERIALS AND METHODS: A stochastic modelwas used to simulate the cost-effectiveness ofliver cancer screening...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Young Hwa, Choi, Kui Son, Jun, Jae Kwan, Suh, Mina, Lee, Hoo-Yeon, Kim, Youn Nam, Nam, Chung Mo, Park, Eun-Cheol, Cho, Woo-Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132454/
https://www.ncbi.nlm.nih.gov/pubmed/25038757
http://dx.doi.org/10.4143/crt.2014.46.3.223
_version_ 1782330630066929664
author Lee, Young Hwa
Choi, Kui Son
Jun, Jae Kwan
Suh, Mina
Lee, Hoo-Yeon
Kim, Youn Nam
Nam, Chung Mo
Park, Eun-Cheol
Cho, Woo-Hyun
author_facet Lee, Young Hwa
Choi, Kui Son
Jun, Jae Kwan
Suh, Mina
Lee, Hoo-Yeon
Kim, Youn Nam
Nam, Chung Mo
Park, Eun-Cheol
Cho, Woo-Hyun
author_sort Lee, Young Hwa
collection PubMed
description PURPOSE: This study was conducted in order to determine the most cost-effective strategy, in terms of interval and age range, forliver cancer screening in the high-risk population of Korea. MATERIALS AND METHODS: A stochastic modelwas used to simulate the cost-effectiveness ofliver cancer screening by combined ultrasonography and alpha-fetoprotein testing when varying both screening intervals and age ranges. The effectiveness of these screening strategies in the high-risk population was defined as the probability of detecting preclinical liver cancer, and costwas based on the direct cost ofthe screening and confirmative tests. Optimal cost-effectiveness was determined using the incremental cost-effectiveness ratio. RESULTS: Among the 36 alternative strategies, one-year or two-year interval screening for men aged between 50 and 80 years, six-month or one-year interval screening for men aged between 40 and 80 years, and six-month interval screening for men aged between 30 and 80 years were identified as non-dominated strategies. For women, identified non-dominated strategies were: one-year interval screening between age 50 and 65 years, one-year or six-month interval screening between age 50 and 80 years, six-month interval screening between age 40 and 80 years, and six-month interval screening between age 30 and 80 years. CONCLUSION: In Korea, a one-year screening interval for men aged 50 to 80 years would be marginally cost-effective. Further studies should be conducted in order to evaluate effectiveness of liver cancer screening, and compare the cost effectiveness of different liver cancer screening programs with a final outcome indicator such as qualityadjusted life-years or disability-adjusted life-years.
format Online
Article
Text
id pubmed-4132454
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Korean Cancer Association
record_format MEDLINE/PubMed
spelling pubmed-41324542014-08-20 Cost-Effectiveness of Liver Cancer Screening in Adults at High Risk for Liver Cancer in the Republic of Korea Lee, Young Hwa Choi, Kui Son Jun, Jae Kwan Suh, Mina Lee, Hoo-Yeon Kim, Youn Nam Nam, Chung Mo Park, Eun-Cheol Cho, Woo-Hyun Cancer Res Treat Original Article PURPOSE: This study was conducted in order to determine the most cost-effective strategy, in terms of interval and age range, forliver cancer screening in the high-risk population of Korea. MATERIALS AND METHODS: A stochastic modelwas used to simulate the cost-effectiveness ofliver cancer screening by combined ultrasonography and alpha-fetoprotein testing when varying both screening intervals and age ranges. The effectiveness of these screening strategies in the high-risk population was defined as the probability of detecting preclinical liver cancer, and costwas based on the direct cost ofthe screening and confirmative tests. Optimal cost-effectiveness was determined using the incremental cost-effectiveness ratio. RESULTS: Among the 36 alternative strategies, one-year or two-year interval screening for men aged between 50 and 80 years, six-month or one-year interval screening for men aged between 40 and 80 years, and six-month interval screening for men aged between 30 and 80 years were identified as non-dominated strategies. For women, identified non-dominated strategies were: one-year interval screening between age 50 and 65 years, one-year or six-month interval screening between age 50 and 80 years, six-month interval screening between age 40 and 80 years, and six-month interval screening between age 30 and 80 years. CONCLUSION: In Korea, a one-year screening interval for men aged 50 to 80 years would be marginally cost-effective. Further studies should be conducted in order to evaluate effectiveness of liver cancer screening, and compare the cost effectiveness of different liver cancer screening programs with a final outcome indicator such as qualityadjusted life-years or disability-adjusted life-years. Korean Cancer Association 2014-07 2014-07-15 /pmc/articles/PMC4132454/ /pubmed/25038757 http://dx.doi.org/10.4143/crt.2014.46.3.223 Text en Copyright © 2014 by the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Lee, Young Hwa
Choi, Kui Son
Jun, Jae Kwan
Suh, Mina
Lee, Hoo-Yeon
Kim, Youn Nam
Nam, Chung Mo
Park, Eun-Cheol
Cho, Woo-Hyun
Cost-Effectiveness of Liver Cancer Screening in Adults at High Risk for Liver Cancer in the Republic of Korea
title Cost-Effectiveness of Liver Cancer Screening in Adults at High Risk for Liver Cancer in the Republic of Korea
title_full Cost-Effectiveness of Liver Cancer Screening in Adults at High Risk for Liver Cancer in the Republic of Korea
title_fullStr Cost-Effectiveness of Liver Cancer Screening in Adults at High Risk for Liver Cancer in the Republic of Korea
title_full_unstemmed Cost-Effectiveness of Liver Cancer Screening in Adults at High Risk for Liver Cancer in the Republic of Korea
title_short Cost-Effectiveness of Liver Cancer Screening in Adults at High Risk for Liver Cancer in the Republic of Korea
title_sort cost-effectiveness of liver cancer screening in adults at high risk for liver cancer in the republic of korea
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132454/
https://www.ncbi.nlm.nih.gov/pubmed/25038757
http://dx.doi.org/10.4143/crt.2014.46.3.223
work_keys_str_mv AT leeyounghwa costeffectivenessoflivercancerscreeninginadultsathighriskforlivercancerintherepublicofkorea
AT choikuison costeffectivenessoflivercancerscreeninginadultsathighriskforlivercancerintherepublicofkorea
AT junjaekwan costeffectivenessoflivercancerscreeninginadultsathighriskforlivercancerintherepublicofkorea
AT suhmina costeffectivenessoflivercancerscreeninginadultsathighriskforlivercancerintherepublicofkorea
AT leehooyeon costeffectivenessoflivercancerscreeninginadultsathighriskforlivercancerintherepublicofkorea
AT kimyounnam costeffectivenessoflivercancerscreeninginadultsathighriskforlivercancerintherepublicofkorea
AT namchungmo costeffectivenessoflivercancerscreeninginadultsathighriskforlivercancerintherepublicofkorea
AT parkeuncheol costeffectivenessoflivercancerscreeninginadultsathighriskforlivercancerintherepublicofkorea
AT chowoohyun costeffectivenessoflivercancerscreeninginadultsathighriskforlivercancerintherepublicofkorea